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Influenza A viruses infect various mammals like human, horse, pig and birds as 
well. A total of 16 hemagglutinin (HA) and 9 neuraminidase (NA) subtypes have 
been identified. Most of the combinations are found in birds and relatively few have 
been isolated from mammals. Although there is no report of human to human 
transmission till to date, several cases of H5N1, H7N7 and H9N2 identified in 
humans since 1997 raised serious concern for health and veterinary profession. This 
review paper will focus H9N2 avian influenza virus (AIV) with special emphasis on 
zoonosis. The virus H9N2 though not highly pathogenic like H5N1 but can be 
virulent through antigenic drift and shift. 
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INTRODUCTION 
 
Avian influenza (AI) viruses are typed as high 
pathogenic avian influenza (HPAI) or low pathogenic 
avian influenza. Office des International Epizooties (OIE) 
set up molecular criteria to identify HPAI. This is based 
on amino acid sequence on HA cleavage site. In vivo it 
will be considered as HPAI if any isolate can kill at least 
75% of susceptible 4-6 weeks old chicken within 10 days 
post inoculation by i/v route (OIE, 2012). AI have the 
tendency to change its genetic makeup and able to cause 
interspecies transmission with zoonotic potential (Aamir 
et al., 2007; Cheema et al., 2011; Khan et al., 2011; 
Siddique et al., 2012). It can be occurred by two ways: 
random mutations in the genome especially in 
hemagglutinin or by reassortment of gene segments 
(Lipsitch  et al., 2012). Based on serological and 
experimental studies in rodents (especially mice and 
hamsters), carnivores, ungulate ruminants can be infected 
with influenza A virus (Swayne and King, 2003). 
Transmission of AIV to human being may occur without 
its binding preferences for α 2,6 linkage due to shared non 
glycoprotein gene constellation which cause limited 
human infection in Hong Kong and China since 1997 
(Blair et al., 2013). Like Influenza A virus many of the 
zoonotic viral disease which has ability to transmit 
between human and animal possess RNA genomes 
(Holmes, 2009). With a low fidelity of having lack of 
exonuclease proofreading ability Influenza A virus (IAV) 
exists as a quasi-species (Furuse et al., 2010). IAVs can 
adopt stably in a variety of animal including human and 
birds. Novel human adapted AIV can cause pandemic 
since 100 years (Taubenberger and Morens, 2009). AIV 
do not replicate well in mammals indicating birds to 
human transmission is unlikely to occur. However, since 
1997 several cases of H5N1, H7N7 and H9N2 identified 
in human raised concern in health and veterinary 
professions. In this paper we reviewed current knowledge 
of AIV H9N2 subtype with special emphasis on zoonosis.  
 
Morphology: Avian influenza virus belongs to the family 
Orthomyxoviridae (Palese and Shaw, 2007). Shape of 
Avian Influenza virus (AIV) varies from spherical to 
filamentous and diameter ranges from 80-120 nm. From 
the viral envelope HA & NA are projected (Palese and 
Shaw, 2007). Till to date 16 HA & 9 NA subtypes have 
been identified. Theoretically 144 possible combinations 
of HA-NA subtype are possible. At least 116 of subtypes 
have been isolated from birds (Krauss et al., 2004; 
Munster et al., 2007). Size of HA is 10-14 nm and NA 4-6 
nm in diameter. The virus belongs to helical symmetry. It 
contains ssRNA with negative sense.  Its genome is 
segmented. It has eight segments. At least 11 ORF (open 
reading frame) are coded by 8 segments. Its genome codes 
for 10 proteins. Out of 10, eight help in structure of virus 
(HA, NA, NP, M1, M2, PB1, PB2 and HA), and rest two 
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are nonstructural proteins (NS1 and NS2) which express 
only during replication of virus in the host cytoplasm 
(Palese and Shaw, 2007). Most ample matrix protein M1 
is settled beneath the viral envelope. Virus makes the 
envelope by taking materials from the infected cell 
membrane and contains multiple copies of the HA and 
NA glycoproteins (Swayne and Halvorson, 2008). Viral 
envelope is chiefly made by cholesterol and 
glycosphingolipid. It is derived from the host cell 
membrane (Swayne et al., 2008).  
HA, NA and M2 (ion channel) protein are hooked in 
the lipid layer of envelope. HA is grouped into type I 
transmembrane protein and it constitutes about 80% of the 
envelope protein. HA is glycosylated and acts as fusion 
and receptor protein. AIV adapted to birds have α 2-3 
sialic acid receptors while in human it has specificity α 2-
6 receptors. After binding with the receptor virus is 
internalized into acidic compartment leads to 
conformational change of HA. In birds it is cleaved by 
exogenous serine protease and in mammals by tryptase 
which is produced by clara cells of bronchiolar 
epithelium. HA mediates in the attachment of virus with 
the susceptible cell and provokes neutralizing antibodies. 
Fusion and virus infectivity depends on cleavability of 
HA.  NA is grouped into type II transmembrane protein. 
Its shape is homotetramer which is hooked into viral 
envelope. NA helps in the elution of virus from the host 
cell and spread of virus through host. M2 is grouped into 
III category of transmembrane protein which acts as an 
ion channel (Swayne and Halvorson, 2008).  M2 is 
required for viral replication and antiviral drug 
adamantine acts on it. Segmented RNA of AIV is 
wrapped by nucleo protein (NP). There are 3 polymerase 
proteins present in the AIV. They are designated as PB1, 
PB2 and PA respectively. PB1 serves as RNA dependent 
RNA polymerase, mRNA is synthesized by PB2. PA is 
required for endonucleolytic cleavage of host RNAs 
(Jeffery and John, 2010). Lipid content of the viral 
envelope plays an important role in entry of virus into a 
susceptible cell. Role of cholesterol in viral envelope was 
assessed by using methyl β cyclodextrin depletion assay. 
It reduces cholesterol from the envelope of virus and 
reduces virus infection considerably. While on naked 
Simian virus 40 did not show any effect. Moreover the 
envelope cholesterol reduction remarkably affects the 
process of influenza virus fusion which is measured by 
fluorescence dequenching assays (Sun and Whittaker, 
2003). 
The influenza virus contains a segmented negative 
sense RNA genome. It buds from the apical portion of the 
epithelium. Mature virion is not formed within cell. Virus 
comprises 3 major components which are envelope, 
matrix and core. The viral envelope encompasses viral 
ribonucleo protein (RNP) consists of lipid bilayer which is 
embedded by spikes build by glycol proteins. Embedded 
M1 protein makes bridge between viral core and 
envelope. Viral core is made up by RNP, RNA, NP 
(nucleoprotein), NEP (nuclear export protein) and 
polymerase complex (PA, PB1 and PB2). Transmembrane 
viral proteins are available in the assembly place of cell 
membrane through exocytic pathway. HA and NA both 
use lipid as a vehicle across the cell surface. These lipids 
which act as vehicle are chiefly composed of cholesterol 
and glycosphingo lipid. Viral nucleic acids are 
manufactured in the nucleus of cell and exported into the 
cytoplasm through nuclear pore (Nayak et al., 2004). 
Matrix is made up of two proteins, M1 and M2. M2 
protein mediates cell penetration, ion channel activity and 
uncoating of nucleic acid (Swayne et al., 2008). Although 
in another study it shows virus lacking M2 can replicate 
without compromising its infectivity (Watanabe et al., 
2001). Nucleo protein serves as structural protein in ribo 
nucleo protein (RNPs). It helps in transcription and 
trafficking of RNP between cytoplasm and nucleus. NS1 
has multiple functions such as increase viral mRNA 
translocation, type I IFN antagonist, inhibiting host 
mRNA processing (Palese and Shaw, 2007). NS2 (nuclear 
export protein) facilitates export of viral RNP.  
 
Molecular Characterization: In laboratory AIV is 
diagnosed by isolating the virus in SPF (specific pathogen 
free) embryonated eggs followed by HI test and NA assay 
on harvested allantoic fluid (OIE, 2012). A variety of PCR 
can be used to diagnose different variants of AIV based 
on matrix or nucleoprotein gene (Kiss et al., 2006). 
Pandemic preparedness is carried in the world wide after 
detection of any novel subtype of HA. Gene analysis of 2 
human H9N2 isolates from Hong Kong revealed that it 
closely resembles with an H9N2 isolate from quail. It also 
contains the genes of isolate of H5N1 virus (Saito et al., 
2001). The human isolate produced respiratory infection 
in Syrian hamster suggesting that it can replicate in 
mammalian host. The 12 genes of NA, H9N2 influenza 
virus strains were isolated from infected poultry in several 
farms in mainland China during 1995–2002 were 
amplified and sequenced. It showed that neuraminidase in 
12 strains had a deletion of 3 amino acid residues at 
positions 63–65 as compared to that of 
A/turkey/Wisconsin/189/66, however the isolates H9N2 
of Korea and Pakistan had no deletion. Phylogenetic 
analysis exhibited that these isolates NA gene were 
related to a duck isolate. The viruses which have been 
isolated show NA gene of the H9N2 viruses belonged to 
different lineage from those of the 12 isolates (Jin et al., 
2006). The results displayed that the gene sequence of NA 
in H9N2 strains which have been isolated in China for the 
last 8 years well conserved. HI assay revealed that 18 out 
of 20 isolates showed cross reactivity with antisera raised 
against 3 isolate. However antigenic diversity among the 
isolates was observed. The antisera did not show cross 
reactivity against two other isolates. By phylogenetic 
analysis it was recorded that 19 out of 20 isolates were 
related to Y-280 sublineage of Eurasia (Chengjun et al., 
2005). One isolate is closely associated with a turkey 
isolate which belongs to North American Lineage. 
Seven H9N2 viruses were isolated in the UAE 
(United Arab Emirates) during 2000-2003. Phylogenetic 
relation of these viruses was studied by comparing with 
the isolated virus in the Middle East and other Asian 
countries. An additional basic amino acid is found at the 
cleavage site of all the viruses. Six out of seven isolates 
have mutation and increased tendency toward human 
receptors (Aamir et al., 2007). More than 90% similarity 
was observed in surface glycoprotein and most internal 
gene of virus were similar to quail isolate. Four amino 
acid substitutions were observed in the hemadsorbing site Pak Vet J, 2013, 33(3): 272-276. 
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of neuraminidase. During 2003-2004, 29 H9N2 AIV 
isolates were obtained from different states of India. 
Subtyping of the virus was carried out by neuraminidase 
inhibition assay, HI and RT-PCR. On sequencing of HA 
gene it showed that isolates were very closely related (95-
99.6%). The isolates showed 92-96% homology with 
other isolates from Asia and Germany. On amino acid 
sequences it shows that it has a tendency to bind with α 2-
6 sialic acid receptor (Nagarajan et al., 2009). Four out of 
six isolates showed glycyosylation at 5
th position in HA1 
cleavability. But remaining two showed at 7
th position of 
glycosylation site. On phylogenetic analysis it showed 
that it had a resemblance with quail isolate. Twelve H9N2 
viruses were isolated in Pakistan in the year 2005-2009. 
The HA sequences showed that it contain leucine instead 
of glutamine at position 226 which is a recognized 
indicator for α 2-6 galactose receptor (Iqbal et al., 2009). 
The NS gene showed considerable genetic variation. It 
showed analogy to H5 or H7 subtype rather than H9N2 
subtype. 
 
Immune response to AIV: AIV elicits host immune 
response resulting abortion of virus replication. In period 
of 21
st century in 2009, new influenza A/ H1N1 virus of 
swine origin causing first pandemic in the world (WHO, 
2009). Besides H5N1, H7N7, and H9N2 of avian origin 
sporadically transmitted from animal to human being (de 
Wit et al., 2008). 
AIV infection is first confronted by innate immune 
system. Initially viral RNA is recognized by pattern 
recognition receptors. It includes retinoic acid inducible 
gene -1 (RIG-1) (Pang and Iwasaki, 2011). Viral RNA 
binds with toll like receptors (TLR7) which provoke 
production of cytokines and type I IFN (Lund et al., 
2004). IFN-α, IFN-ß have strong antiviral activity. Viral 
replication and protein synthesis are blocked by this 
interferon (Sato et al., 1998).  
 
Role of alveolar macrophage in influenza virus 
infection:  Soon after infection, alveolar macrophage 
activate and phagocytose (apoptotic) influenza virus 
infected cell and confine virus disseminate (Tumpey et 
al., 2005; Kim et al., 2008). Once macrophage activated it 
produces TNF α, nitric oxide synthase 2 (NOS2) and leads 
to influenza virus mediated damage (Jayasekera et al., 
2006; Lin et al., 2008). Blood derived macrophage 
infected with influenza H5N1 produce more cytokines in 
contrast to alveolar macrophages (van Riel et al., 2011; 
Khan et al., 2011).  
 
Dendritic cells and their role in influenza specific 
immunity:  In influenza virus infections dendritic cells 
(DC) are regarded as professional antigen presenting cells. 
The conventional DCs (cDC) are located beneath 
respiratory epithelium. It can detect and opsonize virion 
during infection. Upon entry of AIV conventional DCs 
present antigen to T cells to activate them 
(GeurtsvanKessel and Lambrecht, 2008; Hintzen et al., 
2006). Viral proteins are degraded by dendritic cells and 
subsequently MHC class I or class II molecules present 
the epitopes. Viral epitopes are degraded by proteasome 
and liberated into cytosol. Subsequently it is transported 
to endoplasmic reticulum along with MHC class 
molecules. For MHC II presentations viral antigens are 
degraded by lysosome in endosome ((CD11+ DC) 
(GeurtsvanKessel et al., 2009 a,b). 
 
Adaptive Immune System: Influenza virus elicits virus 
specific antibody (Mancini et al., 2011). Surface viral 
proteins HA and NA are important as these produce 
protective immunity (Gerhard, 2001). Antibodies against 
HA prevent the attachment of virus into host cell. It can 
neutralize the virus. It also facilitates phagocytosis by 
expressing Fc receptors in the cell (de Jong et al., 2000). 
Antibodies against NA have a potential protective role 
against AIV infection. Antibodies bind with NA inhibit 
the spread of virus to the adjacent cell. It also facilitates 
antibody dependent cell mediated cytotoxicity 
(Mozdzawoska  et al., 1999). Antibodies against 
nucleoprotein (NP) may contribute to protect against 
avian influenza infection (Carragher et al., 2008). Exact 
role of antibodies is yet to be elucidated. It is believed that 
it can provoke complement associated lysis of infected 
cell (Sambhara et al., 2001). 
 
Cellular immunity: CD4, CD8 and T regulatory cells are 
activated by AIV infection. APCs associated with class II 
MHC molecules present viral peptides to CD4 cells. 
Infected cells are lysed by some CD4 cells (Soghoian and 
Streeck, 2010). IL-4, IL-13 are produced by Th2 cells 
which promotes B cell response (Lamb et al., 1982; 
Wright  et al., 2007). IFN-γ, IL-2 are produced by Th1 
cells which leads to cellular immune response. Influenza 
virus infections activate CD8+ cells and more to site of 
infection. Influenza virus infected cells are recognized 
there by CD8 cells and inhibit the production of progeny 
virion. Perforin and granzyme mediate the lysis of 
infected cells. Permeability of infected cells is increased 
by perforin and subsequently granzyme leads to apoptosis 
of the cell (Metkar et al., 2008; Regner et al., 2009). 
 
H9N2 AIV infections in Human Beings: H9N2 is one of 
the major subtype of avian influenza virus which is 
prevailing among domestic poultry since 1990s (Xu et al., 
2007). Three human infections of H9N2 AIV have been 
reported in Hong Kong between 1999 and 2003 (Butt et 
al., 2005). In a sero survey from 150 blood donors in 
Hong Kong, three individuals had neutralizing antibodies 
against H9N2 (Peiris et al., 1999). The capacity of H9 HA 
surface glycoprotein to bind with the avian and human 
being receptors highlighting it may lead to influenza 
pandemic (Peiris et al., 2001). Analysis of 75 human 
serum samples in USA revealed that 93.3%, 5.3% and 
1.3% individuals had <1:10, 1:10 and 1:20 antibody titer 
against H9 avian influenza virus (Kayali et al., 2008). In 
China, highest antibodies against H9 were reported in 
poultry retailers (15.9%) as compared to other worker 
groups associated with poultry industry (Wang et al., 
2009). In Xinjiang and Liaoning provinces of China, 1.7 
and 1%, respectively seropositivity against H9 virus was 
recorded when sera of poultry workers were analyzed 
through HI test using horse RBCs (Jia et al., 2009). A sero 
survey conducted on (n=300) exposed individuals with 
respiratory signs and healthy unexposed individuals in 
Fars province of Iran revealed higher prevalence of H9N2 
in exposed individuals i.e. butchers and veterinarians Pak Vet J, 2013, 33(3): 272-276. 
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(Hadipour, 2010; Hadipour et al., 2011). A seroprevalence 
of 85.7% and 30.4% against H9 was recorded for 
vaccinators and veterinarians, respectively in Punjab 
province of Pakistan. The higher prevalence rate in 
vaccinators may be attributed to their longer duration of 
exposure as compared to veterinarians. By district wise 
the highest seroprevalence (82.1%) was recorded in Toba 
Tek Singh whereas the lowest (9.7%) was recorded in 
Islamabad (Ahad et al., 2013). 
Intranasal infection of H9N2 in hamster produced 
mild syndrome. Virus was detected in trachea and lungs. 
Sero conversion was detected after 14 days and antibody 
persisted for at least 28 weeks (Qi et al., 2011). 
Occurrence of H9N2 virus infection in two 
immunocompromised individuals revealed that virus can 
also act as opportunistic agent (Cheng et al., 2011). Blair 
et al. (2013) reported significantly higher incidence of 
H9N2 in old age individuals (≥ 60 years) of Cambodia as 
compared to younger ones. The lower incidence in 
younger individuals may be attributed to stronger innate 
immunity in this age which can efficiently eliminate viral 
infection and subsequent production of specific 
antibodies. 12 isolates of H9N2 from Pakistan have been 
studied. It was revealed that nonstructural (NS) gene 
showed greater diversity and it closely resembles with H5 
and H7 subtypes rather than established H9N2 Eurasian 
lineage. The novel gene possessed by H9N2 subtype 
posed a threat of human pandemics (Iqbal et al., 2009).  
 
Conclusion:  An estimated 75% emerging infectious 
diseases are zoonotic, mainly of virus origin. Wild life 
constitutes a large often unknown mysterious reservoir of 
infectious agents which can be source of reemergence of 
previously controlled zoonosis. The pathobiology of 
influenza virus is intrigue and complex. Its intricacy is 
multifaceted like genetic make up of the virus, interaction 
of virus with its host, its genetic diversity and evolution 
with the passage of time. Although we unraveled some of 
the basic questions of the virus but numerous challenges 
have not yet been solved. Future progress requires better 
understanding of structure and functional relation of all 
protein of the virus. 
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